Brief: Jazz Pharmaceuticals Announces Private Offering Of $1.0 Billion Of Exchangeable Senior Notes Due 2032
26/08/2026 12:16
BRIEF-Jazz Pharmaceuticals Announces Private Offering Of $1.0 Billion Of Exchangeable Senior Notes Due 2032 Aug 26 (Reuters) - Jazz Pharmaceuticals PLC JAZZ.O:
JAZZ PHARMACEUTICALS ANNOUNCES PRIVATE OFFERING OF $1.0 BILLION OF EXCHANGEABLE SENIOR NOTES DUE 2032 AND CONCURRENT ORDINARY SHARE REPURCHASES
JAZZ PHARMACEUTICALS - INITIAL PURCHASERS MAY BUY UP TO $150 MILLION ADDITIONAL NOTES WITHIN 13 DAYS
JAZZ PHARMACEUTICALS - EXPECTS TO REPURCHASE UP TO $225 MILLION OF ORDINARY SHARES CONCURRENTLY
JAZZ PHARMACEUTICALS - NET PROCEEDS FROM OFFERING EXPECTED TO BE USED FOR GENERAL CORPORATE PURPOSES
Source text: ID:nPreN6zl9a
Further company coverage: JAZZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jazz Pharmaceuticals
See all newsBrief: Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Jazz Pharma dips after upsized $1.1 bln convertible offering
Brief: Jazz Pharmaceuticals Announces Private Offering Of $1.0 Billion Of Exchangeable Senior Notes Due 2032